Delivery Order SPE2DB22D3004-SPE2DB25FRG32
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,242.12 and a completion date of July 18, 2025. It is not set aside for any particular business type. AmerisourceBergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,541.98 contract is for the delivery of 100-count bottles of 50 mg lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,162.22 and a completion date of June 23, 2025. It is a firm fixed-price contract, indicating a pre-determined price for the items....
- This is a $1,972.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 30 mg capsules, which are a pharmaceutical product used to treat conditions such as ADHD. The contract has an ultimate completion date of July 8, 2025 and does not have a set-aside designation, indicating it was competitively awarded....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,658,661 units of the drug Lisdexamfetamine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $2,916.59 and a completion date of July 25, 2025. The contract is not set aside for any specific business type....
- This is a $6,298.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Lisdexamfetamine 40 mg capsules, a medication used to treat conditions such as attention deficit hyperactivity disorder (ADHD). The delivery order has an ultimate completion date of July 14, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,885.07 contract is for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 20, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lisdexamfetamine 50 mg capsules, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,532.68 and is a firm fixed-price delivery order with a completion date of July 11, 2025. The contract is not set aside for any specific business...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 mg capsules of the medication lisdexamfetamine, a common treatment for ADHD, with a ceiling value of $2,060.30. The contract is a Firm Fixed Price arrangement with a performance period ending on June 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,100.64 and a completion date of June 24, 2025. The contract provides for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). AmerisourceBergen Drug Corp holds a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRG32Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 100 capsules of the drug Lisdexamfetamine 50 mg, a prescription medication used to treat conditions such as attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,229.87 and a period of performance through July 1, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of medical products and supplies to federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/30/25 |